(Q37804948)

23 August 2017

title

Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1 (English)

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

United States Environmental Protection Agency

17 August 2024

main subject

software

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21034758

17 August 2024

author name string

J. Allen Davis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21034758

17 August 2024

Jeffrey S. Gift

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21034758

17 August 2024

Q. Jay Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21034758

17 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21034758

17 August 2024

publication date

27 October 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0041008X10004096?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

https://api.elsevier.com/content/article/PII:S0041008X10004096?httpAccept=text/plain

17 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

Toxicology and Applied Pharmacology

17 August 2024

published in

1 reference

23 August 2017

volume

254

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

181-191

1 reference

Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels.

23 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

A new method for determining allowable daily intakes.

17 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies

17 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

A simulation study of the influence of study design on the estimation of benchmark doses for developmental toxicity.

17 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints

17 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

Dose-response modeling of continuous endpoints.

17 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

Testing the statistical certainty of a response to increasing doses of a drug

17 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation

17 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

The benchmark approach applied to a 28-day toxicity study with Rhodorsil Silane in rats. the impact of increasing the number of dose groups

17 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.10.016

17 August 2024

Identifiers

1 reference

23 August 2017

1 reference